1. Home
  2. UG vs SCLX Comparison

UG vs SCLX Comparison

Compare UG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • SCLX
  • Stock Information
  • Founded
  • UG 1942
  • SCLX 2011
  • Country
  • UG United States
  • SCLX United States
  • Employees
  • UG N/A
  • SCLX N/A
  • Industry
  • UG Package Goods/Cosmetics
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UG Consumer Discretionary
  • SCLX Health Care
  • Exchange
  • UG Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • UG 36.1M
  • SCLX 35.7M
  • IPO Year
  • UG N/A
  • SCLX N/A
  • Fundamental
  • Price
  • UG $7.81
  • SCLX $19.38
  • Analyst Decision
  • UG
  • SCLX Strong Buy
  • Analyst Count
  • UG 0
  • SCLX 3
  • Target Price
  • UG N/A
  • SCLX $367.50
  • AVG Volume (30 Days)
  • UG 10.2K
  • SCLX 326.9K
  • Earning Date
  • UG 08-08-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • UG 8.95%
  • SCLX N/A
  • EPS Growth
  • UG N/A
  • SCLX N/A
  • EPS
  • UG 0.56
  • SCLX N/A
  • Revenue
  • UG $10,856,174.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • UG N/A
  • SCLX $89.26
  • Revenue Next Year
  • UG N/A
  • SCLX $203.95
  • P/E Ratio
  • UG $14.14
  • SCLX N/A
  • Revenue Growth
  • UG N/A
  • SCLX N/A
  • 52 Week Low
  • UG $7.73
  • SCLX $3.60
  • 52 Week High
  • UG $16.25
  • SCLX $46.20
  • Technical
  • Relative Strength Index (RSI)
  • UG 39.20
  • SCLX 67.78
  • Support Level
  • UG $7.80
  • SCLX $16.60
  • Resistance Level
  • UG $8.23
  • SCLX $22.01
  • Average True Range (ATR)
  • UG 0.28
  • SCLX 2.26
  • MACD
  • UG -0.03
  • SCLX 0.23
  • Stochastic Oscillator
  • UG 1.45
  • SCLX 72.08

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: